Novel compounds represented by formula (I): ##STR00001## wherein R.sub.1,
R.sub.2, R.sub.3 and R.sub.4 are as defined herein, and pharmaceutically
acceptable salts, hydrates and solvates thereof, are useful for the
modulation of CCR5 chemokine receptor activity.